| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |